Deutsche Bank
GNMX

Deutsche Bank’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Deutsche Bank’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10
Closed – – 5576
2018
Q3 		$0 Buy
+10
New +$11 ﹤0.01% 5664
2018
Q2 		– Sell
-69
Closed – – 5696
2018
Q1 		$0 Hold
69
– – ﹤0.01% 5725
2017
Q4 		$0 Hold
69
– – ﹤0.01% 5239
2017
Q3 		$0 Sell
69
-1
-1% -$1 ﹤0.01% 5207
2017
Q2 		$0 Sell
70
-6,579
-99% -$9.51K ﹤0.01% 5220
2017
Q1 		$12K Sell
6,649
-7,981
-55% -$36.1K ﹤0.01% 4593
2016
Q4 		$75K Buy
14,630
+10,076
+221% +$53K ﹤0.01% 4211
2016
Q3 		$25K Buy
4,554
+830
+22% +$4.73K ﹤0.01% 4479
2016
Q2 		$20K Buy
3,724
+383
+11% +$2.01K ﹤0.01% 4759
2016
Q1 		$14K Sell
3,341
-2,241
-40% -$9.22K ﹤0.01% 4746
2015
Q4 		$32K Buy
5,582
+938
+20% +$6.37K ﹤0.01% 4600
2015
Q3 		$36K Sell
4,644
-4,800
-51% -$37.2K ﹤0.01% 4579
2015
Q2 		$57K Buy
+9,444
New +$73.2K ﹤0.01% 4521
2015
Q1 		– Sell
-17,197
Closed -$87K – 6215
2014
Q4 		$87K Buy
+17,197
New +$84.9K ﹤0.01% 4812
2013
Q4 		– Sell
-1
Closed – – 5827
2013
Q3 		$0 Sell
1
-799
-100% -$3.71K ﹤0.01% 5823
2013
Q2 		$3K Buy
+800
New +$3.28K ﹤0.01% 5133

Other funds holding GNMX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's GNMX Position: Q4 2018 in Review

Deutsche Bank sold out of Aevi Genomic Medicine Inc (GNMX) in Q4 2018, closing a stake of 10 shares.

Deutsche Bank first reported a position in GNMX in Q2 2013 and held it in 16 quarters. The position peaked at $87K in Q4 2014. 38 funds tracked by Wall St. Rank hold GNMX as of Q4 2018.

  • Deutsche Bank reported no remaining Aevi Genomic Medicine Inc position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 10 Aevi Genomic Medicine Inc shares in Q4 2018.
  • Deutsche Bank first reported a position in Aevi Genomic Medicine Inc in Q2 2013 and held it in 16 quarters.
  • Deutsche Bank's Aevi Genomic Medicine Inc position peaked at $87K in Q4 2014.
  • 38 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.